Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML. [electronic resource]
Producer: 20171212Description: 1561-1564 p. digitalISSN:- 1476-5365
- Adolescent
- Adult
- Aged
- Blood Donors
- Cyclophosphamide -- administration & dosage
- Female
- Graft Survival
- Graft vs Host Disease -- prevention & control
- Haplotypes
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Histocompatibility
- Humans
- Leukemia, Myeloid, Acute -- complications
- Male
- Middle Aged
- Premedication
- Retrospective Studies
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.